home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  February 26, 2024
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 473 active entries

Fyodor Biotechnologies Ltd

26 Ogui Road, Third Floor
Enugu, Enugu State

Phone: 042-303345
E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.


Fyodor Biotechnologies Ltd is engaged in applied research, development and manufacture of biomedical products in Nigeria, and focused on addressing diseases most prevalent in Africa. Our business is to make essential diagnostics and biopharmaceuticals that are critical to the healthcare needs of our people and to make these products readily available so that more of people can afford the medications they need.

We believe that biotechnology can make important contributions in the areas of healthcare, food security and environmental sustainability on the continent. Therefore, we bring this new knowledge to address old problems through the direct application of relevant biotechnologies in select critical disease areas through leading-edge application and science-based innovation. 

As a local company founded by seasoned African professionals, Fyodor is building high-end local capacity considered an important socioeconomic investment that is essential for improving availability and access to healthcare products in a sustainable manner. Fyodor seeks to maintain success as a biotechnology adapter and extender, an enhancer of new competencies, and through these efforts, drive high technology development and growth in  Africa. Gladly, we are backed by our first-hand understanding of the local disease challenges and the socio-cultural issues surrounding biotechnology. 

Fyodor's product, the Urine Malaria Test, a urine-based point-of-care test for the diagnosis of malaria in persons who present with fever, will be commercialized in Nigeria in Q3 2014.


Selected Categories:
Product Company   Service Company
- General
- Research
- General
- Research
- in vitro

Last update of this entry: November 06, 2013

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.